- Home
- GWRS vs PLX Comparison
GWRS vs PLX Comparison
Compare GWRS & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GWRS | PLX |
|---|---|---|
| Founded | 2003 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.6M | 182.9M |
| IPO Year | 2008 | 1996 |
Fundamental Metrics
Financial Performance| Metric | GWRS | PLX |
|---|---|---|
| Price | $8.63 | $2.24 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $9.20 | ★ $12.00 |
| AVG Volume (30 Days) | 92.5K | ★ 686.8K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.22% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.08 | ★ 0.27 |
| Revenue | $41,914,000.00 | ★ $52,744,000.00 |
| Revenue This Year | $15.29 | $36.81 |
| Revenue Next Year | $8.28 | N/A |
| P/E Ratio | $111.13 | ★ $8.74 |
| Revenue Growth | ★ 8.51 | N/A |
| 52 Week Low | $6.55 | $1.47 |
| 52 Week High | $11.17 | $3.19 |
Technical Indicators
Market Signals| Indicator | GWRS | PLX |
|---|---|---|
| Relative Strength Index (RSI) | 75.63 | 42.68 |
| Support Level | $8.42 | $2.19 |
| Resistance Level | $8.88 | $2.43 |
| Average True Range (ATR) | 0.34 | 0.13 |
| MACD | 0.15 | -0.01 |
| Stochastic Oscillator | 89.30 | 5.94 |
Price Performance
Historical ComparisonAbout GWRS Global Water Resources Inc.
Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix and Tucson, Arizona. It operates within the State of Arizona. Operating revenue of the company is derived from regulated water, wastewater, and recycled water service provided to customers based upon tariff rates.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.